Phil Parkinson can have few concerns after the start Wrexham have made to life in League One, but the manager is especially pleased with the strength in depth running through his squad this campaign.

Wrexham manager Phil Parkinson says his players are "recharged" after the international break - even though they were keen to continue with their impressive form of late. The Dragons are currently ...

AbbVie (NYSE: NYSE:ABBV) today announced the FDA approval of VYALEV™, the first subcutaneous 24-hour continuous infusion therapy for adults with advanced Parkinson's disease. This new treatment ...

AbbVie Inc. said Thursday the Food and Drug Administration has approved its vyalev as the first and only subcutaneous 24-hour continuous ... fluctuations in advanced Parkinson’s disease.

Critically, they find that immune challenge is ... A Risky Business: Why Do Some Parkinson's Disease Treatments Affect Decision Making? Sep. 24, 2024 — Parkinson's disease, a debilitating ...

as the first and only subcutaneous 24-hour infusion of levodopa-based therapy for motor fluctuations in adults with advanced Parkinson’s disease (PD). The approval was supported by the pivotal ...

NORTH CHICAGO, Ill. - AbbVie (NYSE: NYSE:ABBV) today announced the FDA approval of VYALEV™, the first subcutaneous 24-hour continuous infusion therapy for adults with advanced Parkinson's disease.

Wrexham have won six of their 10 League Two games so far this season Wrexham manager Phil Parkinson says his players are "recharged" after the international break - even though they were keen to ...

Millers boss Steve Evans keeps calling Wrexham ‘the Harlem Globetrotters’ but Phil Parkinson won’t be too interested in that comparison. Wrexham are tough and hard to beat, a far cry from the flashy ...

Wrexham boss Phil Parkinson continues to drive the club forward and he seemingly isn’t going anywhere any time soon. The October international break is coming to an end and Wrexham fans will be ...